Skip to main content
HomeInvestors hubShareholder information
Business man

Shareholders

Investor news

OSE Notice
Photocure ASA: Results for the fourth quarter of 2024
Oslo, Norway
19 February 2025
PRESS-RELEASE
News on Richard Wolf/Photocure Collaboration: Interim Flexible BLC solution available in countries where System blue and Richard Wolf reusable flexible cystoscopes are cleared
Oslo, Norway
17 February 2025
PRESS-RELEASE
Bladder Cancer: Upstaging and risk mitigation with Blue Light Cystoscopy in NMIBC featured at ASCO GU 2025
Oslo, Norway
17 February 2025
OSE Notice
Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2024 financial results
Oslo, Norway
12 February 2025
NEWS POST
Photocure Partner Asieris awarded "Annual Star of Innovation" with Hexvix at the 5th Annual Lunjian Awards 2024
Oslo, Norway
22 January 2025
OSE Notice
Photocure ASA: Transactions made under share buyback program
Oslo, Norway
16 January 2025
OSE Notice
Photocure ASA: Transactions made under share buyback program
Oslo, Norway
13 January 2025
OSE Notice
Photocure ASA: Transactions made under share buyback program
Oslo, Norway
5 January 2025
OSE Notice
Photocure ASA - Share option grant
Oslo, Norway
23 December 2024
OSE Notice
Photocure ASA: Initiation of a share buyback
Oslo, Norway
19 December 2024
OSE Notice
Photocure ASA: Notification of primary insider transaction
Oslo, Norway
3 December 2024
OSE Notice
Photocure ASA: Notification of primary insider transaction
Oslo, Norway
3 December 2024
OSE Notice
Photocure ASA: Results for the third quarter of 2024
Oslo, Norway
13 November 2024
NEWS POST
Cevira in Cervical HSIL: Asieris Announces Presentation of Data at the 2024 IPVC Conference Highlighting the Clearance Rate for Different HPV Types
Oslo, Norway
12 November 2024
OSE Notice
Photocure ASA: Invitation to presentation of third quarter 2024 financial results
Oslo, Norway
6 November 2024
OSE Notice
Photocure Partner Asieris announces Marketing Approval by the National Medical Products Administration for Hexvix in China
Oslo, Norway
5 November 2024